Glycopyrrolate Injection
Product Images NDC 65145-102

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Glycopyrrolate (NDC 65145-102). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Caplin Steriles Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image1 (Glycopyrrolate 01)

Chemical structure diagram of Glycopyrrolate showing its molecular arrangement, including rings and functional groups, with molecular formula C19H28BrNO3 and molecular weight 398.33.*

FDA Label Image

Image2 (Glycopyrrolate 02)

Label for Glycopyrrolate Injection, USP 0.2 mg/mL, a single-dose 1 mL vial for intramuscular or intravenous use. Contains benzyl alcohol as a preservative. Manufactured by Caplin Steriles Limited, India. Includes NDC 65145-102-01 and barcode on the label.*

FDA Label Image

Image3 (Glycopyrrolate 03)

Packaging label for Glycopyrrolate Injection, USP 0.2 mg/mL. The label indicates 25 single-dose vials of 1 mL each, containing benzyl alcohol. It specifies the product is for intramuscular or intravenous administration and notes it is not for use in newborns. The label is marked Rx only with NDC 65145-102-25.*

FDA Label Image

Image4 (Glycopyrrolate 04)

Packaging label for Glycopyrrolate Injection, USP 0.2 mg/mL by Caplin Steriles Limited. The box contains 25 single-dose vials of 1 mL each. The label notes the presence of benzyl alcohol, warns that it is not for use in newborns, and specifies administration by intramuscular or intravenous routes.*

FDA Label Image

Image5 (Glycopyrrolate 05)

Glycopyrrolate Injection, USP 0.4 mg/2 mL (0.2 mg/mL) single dose vial label showing intramuscular and intravenous use. The label includes the National Drug Code (NDC) 65145-103-01 and states it contains benzyl alcohol. Manufactured by Caplin Steriles Limited, India. Barcode and lot/expiration fields are also visible.*

FDA Label Image

Image6 (Glycopyrrolate 06)

Packaging label for Glycopyrrolate Injection, USP, 0.4 mg/2 mL (0.2 mg/mL) in single-dose vials. The label includes warnings such as 'NOT FOR USE IN NEWBORNS' and specifies that the product contains benzyl alcohol for intramuscular or intravenous administration. The package contains 25 vials of 2 mL each. Labeler is Caplin Steriles Limited.*

FDA Label Image

Image7 (Glycopyrrolate 07)

Packaging label for Glycopyrrolate Injection, USP 0.4 mg/2 mL (0.2 mg/mL) by Caplin Steriles Limited. The label states it contains 25 x 2 mL single dose vials, labeled for intramuscular or intravenous use. It includes storage instructions and a warning that the product is not for use in newborns. The label also notes the presence of benzyl alcohol as a preservative.*

FDA Label Image

Image8 (Glycopyrrolate 08)

Label for Glycopyrrolate Injection, USP, 1 mg/5 mL (0.2 mg/mL) in a 5 mL multiple dose vial. The label indicates it is for intramuscular or intravenous use and contains benzyl alcohol as a preservative. It includes a warning that it is not for use in newborns. Manufactured by Caplin Steriles Limited, India.*

FDA Label Image

Image9 (Glycopyrrolate 09)

Packaging label for Glycopyrrolate Injection, USP 1 mg/5 mL (0.2 mg/mL) from Caplin Steriles Limited. The label indicates the product contains 25 multiple dose vials of 5 mL each and is for intramuscular or intravenous administration. It includes warnings that it is not for use in newborns and that it contains benzyl alcohol.*

FDA Label Image

Image10 (Glycopyrrolate 10)

Packaging label for Glycopyrrolate Injection USP, 1 mg/5 mL (0.2 mg/mL), in 25 x 5 mL multiple dose vials. The label states it is for intramuscular or intravenous administration, contains benzyl alcohol, and is manufactured by Caplin Steriles Limited. Warning indicates it is not for use in newborns.*

FDA Label Image

Image11 (Glycopyrrolate 11)

Label for Glycopyrrolate Injection, USP, 4 mg/20 mL (0.2 mg/mL) multiple dose vial. Contains benzyl alcohol as preservative. For intramuscular or intravenous use. Includes storage instructions at 20° to 25° C and caution: not for use in newborns. Manufactured by Caplin Steriles Limited, India.*

FDA Label Image

Image12 (Glycopyrrolate 12)

Packaging label for Glycopyrrolate Injection, USP 4 mg/20 mL (0.2 mg/mL) by Caplin Steriles Limited. The label indicates a package of 10 multiple dose vials, each vial 20 mL. It specifies intramuscular or intravenous use and contains benzyl alcohol. A warning states it is not for use in newborns.*

FDA Label Image

Image13 (Glycopyrrolate 13)

Packaging label for Glycopyrrolate Injection, USP 4 mg/20 mL (0.2 mg/mL) by Caplin Steriles Limited. The label indicates a package of 10 multiple dose vials, each containing 20 mL. It specifies intramuscular or intravenous administration and includes storage instructions and warnings such as 'NOT FOR USE IN NEWBORNS' and presence of benzyl alcohol as a preservative.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.